Esperion Therapeutics, Inc. · NASDAQ:ESPR
Glazer Capital, LLC reported a 8.15% stake in Esperion Therapeutics, Inc. (Schedule 13G)
Event Jun 1, 2026 · Filed Jun 8, 2026
Glazer Capital, LLC reported a 8.15% stake in Esperion Therapeutics, Inc., 20,975,620 shares, as a passive investor on Jun 1, 2026. Filed Jun 8, 2026 (Schedule 13G).
- Stake
- 8.15%
- Shares
- 20,975,620
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Glazer Capital, LLC | 8.15% | 20,975,620 |
| Paul J. Glazer | 8.15% | 20,975,620 |
Source
Related
- Esperion Therapeutics, Inc.
- Glazer Capital, LLC
- Esperion Therapeutics, Inc. shareholders
- Schedule 13G · Goldman Sachs Group Inc · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Wasatch Advisors LP · Jul 14, 2026
- Form 4 · Hoffman Robert E. · Jul 13, 2026
- Form 4 · Carroll J Martin · Jul 13, 2026